Mission Statement

The Department of Pharmacognosy carries out research in pharmaceutical sciences focused on natural products from medicinal plants and microorganisms. Major tasks are the discovery of new biologically active compounds from natural sources and the characterization of their molecular mode of action contributing to a better understanding of the interaction of natural products and complex cellular systems. Our aim is pharmaceutical lead and target identification, the quality improvement of herbal medicinal products as well as the sustainable production of natural products by biotechnological approaches.

1 2 3 4 ...

Das einst in der Volksmedizin sehr beliebte Edelweiß kann mittlerweile gezüchtet werden. Die Heilkräfte der Inhaltsstoffe wurden von Forschern wiederentdeckt. Interview mit Brigitte Kopp und Christoph Wawrosch (ORF NÖ HEUTE, 01.04.2019).


Pharma and Food - Lecture Series

07.03. - 27.06.2019


Katharina Waldbauer successfully passed her defensio entitled "Evaluation of fruit pomace constituents as activators of the endothelial nitric oxide synthase (eNOS)” on February 13, 2018. Supervisor: Brigitte Kopp.


„Xanthones from Metaxya rostrata as promising new lead compounds for cancer therapy“ by Eva Mittermair (Department of Pharmacognosy, Institute of Cancer Research).


... gewinnen zunehmend an Bedeutung. Das hat eine Analyse von knapp 300.000 wissenschaftlichen Arbeiten eines Teams um den Molekularbiologen Atanas G. Atanasov ergeben. Die Ergebnisse sind kürzlich in der Fachzeitschrift "Oxidative Medicine and Cellular Longevity" erschienen.


A new antibiotic, named viennamycin, was isolated from a soil-dwelling bacterium of the genus Streptomyces in the Pharmaceutical biotechnology group (head Sergey B. Zotchev). This work is supported by Austria Wirtschaftsservice Gesellschaft mbH, project P1715748-WZP01 “Viennamycin Antibiotika”.

1 2 3 4 ...